Skip to content

Theta Burst Stimulation for motor impairment after stroke

Enhancing the effect of physical therapy for motor impairment after stroke with Theta Burst Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN03884521
Enrollment
45
Registered
2010-04-29
Start date
2005-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Stroke Research Network

Interventions

Physical therapy (physiotherapy): The protocol for physical therapy has been developed in collaboration with the therapy services department at the National Hospital for Neurology and Neurosurgery. I

Sponsors

University College London Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. History of a single ischaemic stroke, initially affecting the hand 2. Minimum interval since stroke onset one year (no upper limit) 3. Residual impairments of hand function (strength and/or dexterity) 4. Some degree of hand movement defined as present wrist extension (>=20%) and ability to grasp 5. Capable of giving informed consent 6. Aged 18 - 80 years, either sex

Exclusion criteria

Exclusion criteria: 1. Intracerebral hemorrhage 2. Large ischaemic lesions involving almost the whole MCA territory 3. Significant tone problems in the hand (greater than 2 in the Ashworth Scale) 4. Severe cognitive impairment defined as mini-mental state examination (MMSE) less than 20 5. Residual aphasia or visual field defect (greater than or equal to 2 in the relative item of the National Institutes of Health Stroke Scale [NIHSS]) 6. Past or current history of other neurological or psychiatric disease including epilepsy, previous or recurrent stroke and peripheral neuropathy 7. Major systemic illness 8. Use of anticonvulsant, psychotropic or sedative or medication 9. Excessive use of alcohol or other substances 10. Accepted contraindications for TMS (presence of metal in the head (excluding the mouth), intracardiac lines, cardiac pacemakers)

Design outcomes

Primary

MeasureTime frame
Action Research Arm Test, measured at initial assessment, 2 day post-intervention follow-up, 1 month follow-up and 3 month follow-up.

Secondary

MeasureTime frame
1. Electrophysiological measures of corticospinal excitability, intracortical interactions and interhemispheric balance, measured at initial assessment, 2 day post-intervention follow-up, 1 month follow-up and 3 month follow-up 2. Functional Magnetic Resonance Imaging: Measurement of motor and sensory related brain activation only performed at initial and two day post intervention follow-up

Countries

Italy, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026